COLL — Collegium Pharmaceutical Inc

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

About Collegium Pharmaceutical Inc

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. The company's portfolio includes Jornay PM, a central nervous system stimulant prescription medicine that contains methylphenidate HCl for the treatment of attention deficit hyperactivity disorder; Belbuca, a buccal film that contains buprenorphine for severe and persistent pain that requires an ex… Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$33.37
Market Cap$1.13B
Float32.0M
Shares Outstanding32.4M
P/E (Forward)4.63
P/E (TTM)16.85
Price/Sales (TTM)1.41
vs. Analyst Target+62.8% to analyst PT
Profit Margin9.41%
Operating Margin (TTM)15.97%
Revenue (TTM)$796M
Earnings Growth (YoY)-46.60%
Dividend RateNone
Analyst Target Price$54.33 (5 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 $310M $26.8M $180M $118M
2021 $277M $71.5M $151M $86.6M
2022 $464M -$25.0M $209M $173M
2023 $567M $48.2M $326M $308M
2024 $631M $69.2M $377M $342M
2025 $781M $62.9M $463M $401M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 $188M $12.0M
Sep 2025 $209M $31.5M
Dec 2025 $205M $17.0M
Mar 2026 $194M $14.5M

Ownership & Float

Insider Ownership1.2%
Institutional Ownership127.7%
Short Float18.5%
% of All Funds Holding2.96%
Number of Funds Holding243

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$34.05Near-term / short-term trend
Weekly40-Week SMA$39.69Medium-term trend
Weekly80-Week SMA$35.05Cyclical trend (business cycle)
Weekly200-Week SMA$30.58Secular trend (multi-year)
Monthly10-Month SMA$39.05Near-term monthly trend
Monthly20-Month SMA$34.52Medium-term monthly trend
Monthly40-Month SMA$32.02Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$41.00 resistance 1.56x 1 months ago
$29.90 support 1.15x 8 months ago

Historical Earnings Reactions (45 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap 0.95% 0.61% 55.56% 14.60% -16.22%
1 Day 2.62% 2.60% 60.00% 31.39% -17.31%
1 Week 2.95% 3.11% 60.00% 67.70% -28.54%
2 Weeks 3.76% 4.82% 55.56% 67.60% -26.99%
1 Month 5.40% 4.80% 54.55% 78.56% -36.80%

Next earnings: July 26, 2026 (58 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan4.1%54.5%11
Feb0.3%54.5%11
Mar-6.9%54.5%11
Apr-2.6%27.3%11
May-4.7%30.0%10
Jun3.2%54.5%11
Jul-0.6%54.5%11
Aug-3.6%45.5%11
Sep13.6%45.5%11
Oct-3.8%36.4%11
Nov21.2%81.8%11
Dec5.8%54.5%11

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday -0.11% 47.4% 519
Tuesday -0.12% 48.9% 573
Wednesday 0.19% 48.9% 569
Thursday 0.36% 50.3% 559
Friday 0.17% 51.6% 558

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 127.7%

Insider Transactions — Smart Summary

Total insider ownership: 1.2%

12-Month Insider Activity Summary

Total Filings18
Net Value-$5.5M
Net Shares Change-131,175
% of Float-0.4%
C-Suite Filings8
Clusters Detected2

Key Insiders

NameTitleNet ValueFilingsActivity
Dreyer Scott EVP and Chief Commercial Officer -$2.0M 1 N/A
Smith Thomas B EVP and Chief Medical Officer -$671,576.42 1 1 sell
Dieter David EVP and General Counsel -$488,099.222 1 N/A
Freund John Gordon -$400,405.129 3 3 sell
BOHLIN GAREN G -$180,028.23 1 1 sell
Balice-Gordon Rita J. -$171,673.37 1 1 sell
Lurker Nancy -$161,860.95 1 1 sell
SANTINI GINO +$731.564 1 1 sell

Transaction Clusters

PeriodFilingsInsidersNet ValueSeniority
2025-08-12 – 2025-08-20 5 4 -$1.7M 2 C-suite
2026-05-13 – 2026-05-20 4 3 -$341,653.76

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-05-18 Freund John Gordon +$916.42 Transaction at $25.52, now +30.8%
2026-05-15 Lurker Nancy -$161,860.95 Transaction at $35.97, now -7.2%
2026-05-20 Freund John Gordon -$681 Transaction at $34.05, now -2.0%
2026-05-13 BOHLIN GAREN G -$180,028.23 Transaction at $26.84, now +24.3%
2025-09-03 Smith Thomas B EVP and Chief Medical Officer -$671,576.42 Transaction at $38.42, now -13.2%
2025-12-09 Balice-Gordon Rita J. -$171,673.37 Transaction at $47.03, now -29.1%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Collegium Pharmaceutical Inc (COLL) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for COLL on Trend Edge →